close

May 1, 2025

Crown Bioscience and NEXT Oncology Cement Partnership Extension

April 28, 2025

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies

March 13, 2025

Crown Bioscience Appoints John Gu as Chief Executive Officer

February 17, 2025

Crown Bioscience Completes Merger with Indivumed Services

February 11, 2025

Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation

December 11, 2024

Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership

December 10, 2024

Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation

Contact Us
Biospecimen Request
Databases
CrownLink

US Tel: +1 858 622 2900

UK Tel: +44 870 242 2900

All Contact Information

Our Services
Our Science
About Us
Contact us

Blog

PARP inhibitors

PARP Inhibitors: Where Are We in 2024 and What’s Coming Next?

4 minute read

PARP Inhibitors: Where Are We in 2024 and What’s Coming Next?

July 18, 2024

Developing Effective Dosing Strategies by Leveraging 3D In Vitro Models

8 minute read

Developing Effective Dosing Strategies by Leveraging 3D In Vitro Models

July 29, 2022

PARP Inhibitors: Where Are We in 2020 and What’s Coming Next?

6 minute read

PARP Inhibitors: Where Are We in 2020 and What’s Coming Next?

April 28, 2020

Search our Blog

Categories

About Us

Our Company
Our Purpose
Our Responsibility
Leadership
News & Events

Our Services

Platforms
Target Solutions
Technologies
Service Type

Resources

Blog
Preclinical Models
Publications
Factsheets
White Papers
Ebooks
Webinars

Platforms

OncoExpress™
XenoBase®
MuBase®
HuBase™
OrganoidBase™
CrownLink™

Talk To Us

+1 858 381 3547
Contact Us
Distributors
LinkedIn
X

© 2025 Crown Bioscience. All Rights Reserved.

Privacy Policy | Imprint | Terms of Service | Privacy Preferences

© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy

2025-03-03

2022-12-16